Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 3.60M | - | $ 7.50M | - | $ 250.00K |
| Operating Income | $ -123.99M | $ -157.13M | $ -146.12M | $ -117.95M | $ -68.55M |
| EBITDA | $ -98.52M | $ -150.61M | $ -141.48M | $ -113.79M | $ -64.16M |
| Net Income | $ -117.17M | $ -154.54M | $ -145.54M | $ -117.51M | $ -64.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 173.01M | $ 308.37M | $ 439.76M | $ 482.57M | $ 222.73M |
| Total Debt | $ 75.04M | $ 106.80M | $ 102.99M | $ 30.71M | $ 32.25M |
| Net Debt | $ -21.49M | $ -78.79M | $ -202.19M | $ -399.02M | $ -133.79M |
| Total Liabilities | $ 89.54M | $ 126.85M | $ 123.54M | $ 48.22M | $ 47.77M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -91.71M | $ -119.91M | $ -122.95M | $ -90.14M | $ -68.42M |
| Operating Cash Flow | $ -90.90M | $ -108.09M | $ -107.83M | $ -78.29M | $ -49.17M |
| Investing Cash Flow | |||||
| Financing Cash Flow |